|
|
 |
|
Viewing report
|
|
|
|
Optimizing Treatment for Metastatic Clear Cell Renal Cell Carcinoma: US Oncologist Survey
The Assessment Group, Feb 2011, Pages: 29
Two patient specific case scenarios that unfold throughout the report, presented to 119 high-prescribing oncologists on Metastatic Clear Cell Renal Cell Cancer for their open responses on clinical decisions. Patient progression reveals decisions in treatment throughout patient stages, factors influencing their decisions, barriers to optimal care, and confidence in treatment.
Patients include:
1) Elderly patient with good prognosis metastatic clear cell carcinoma
2) Clear cell carcinoma and comorbidities
Data has been synthesized to show the highest reported responses, “other” responses, and direct quotes from the oncologists. This is the primary research for the oncology prescribing data that you are missing - directly from high-prescribing US oncologists on Metastatic Clear Cell Renal Cell Cancer.
Treatment decisions for advanced stages of renal cell cancer are difficult to track as information quickly changes along with the introduction of new products that all have an impact oncologists' choices. This report is part of a series of oncology reports that allow you to see what is actually happening at the patient level for different types of patients presenting with a wide range of issues in advanced stages of cancer.
This report allows you to:
- Understand what occurs with actual patients
- Access the most up-to-date prescribing trends
- Gain actionable data for developing and improving your market strategies
- Pinpoint needs of your target audience
- Focus resources to maximize the effectiveness of your budget
- Understand where your product fits
- Understand where your competitor's product fits
- Design messages to advance brand performance
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
